Nierenfunktionsbestimmungen mit Clearance: Methoden und Indikationen

Zusammenfassung

Um die Nierenfunktion quantitativ zu beurteilen, gibt es viele Methoden. Meistens benutzten die Kliniker die simple Bestimmung des Plasmakreatinins; einige wählen jedoch die Kreatininclearance mit Urinsammlung oder andere alternative, aber indirekte, Methoden. Zur quantitativen Nierenfunktionsmessung ergibt die Isotopenclearance jedoch im Vergleich zu anderen Methoden eine hohe Genauigkeit, ist meist einfach durchzuführen und verursacht eine äußerst geringe Strahlenbelastung. In diesem Überblick werden die unterschiedlichen Radiopharmaka für die Isotopenclearance, deren Vor- und Nachteile, sowie der Clearancebegriff und die unterschiedlichen Clearancetechniken besprochen. Auch eine Zusammenstellung von klinisch wichtigen Indikationen wird genannt. Die Plasmaclearance mit 51-Cr-EDTA nach einmaliger Injektion und mit einer Plasmaprobe ist die meist empfohlene Methode. Bei gewissen speziellen klinischen Situationen empfehlen sich jedoch Modifikationen, die beschrieben werden.

Abstract

Renal function impairment can be monitored by many tests. Measurement of plasma-creatinine level is the most used method, 24 hour plasma-creatininclearance with urine collection is used by others and also other alternative but indirect methods exist. However, the use of radionuclide-clearances is by far the easiest performed method with the highest accuracy and precision and gives very low irradiation dose. In the following we will discuss the different radiopharmaceuticals in use, their plus and minus, the different clearance methods in use, their limitations and give some clinically important indications to perform clearance investigations according to consensus reports. Summarizing the use of plasma clearance of 51-Cr-EDTA after a single injection with one blood sample can be generally recommended, however with some modifications in special clinical situations, which are pointed out.

Clearance - GFR - Isotopenclearance - 51-Cr-EDTA-„slope”-Clearance - MAG-3-Clearance

Clearance - GFR - radionuclide clearance - 51-Cr-EDTA single injection clearance - MAG-3 clearance

Literatur

• 1 Bland J M, Altman D G. Statistical methods for assessing agreement between two methods of clinical measurement.  Lancet. 1986;  1 307-310
• 2 Blaufox M D, Aurell M, Bubeck B, Fommei E, Piepsz A, Russell C. et al . Report of the Radionuclides in Nephrourology Committee on renal clearance.  J Nucl Med. 1996;  37 1883-1890
• 3 Boyd E. Growth of the surface area of the human body. In: University of Minnesota Press, Minnesota 1935; 132
• 4 Brøchner-Mortensen J. A simple method for the determination of glomerular filtration rate.  Scand J Clin Lab Invest. 1972;  30 271-274
• 5 Brøchner-Mortensen J. Current status on assessment and measurement of glomerular filtration rate.  Clin Physiol. 1985;  5 1-17
• 6 Brøchner-Mortensen J, Freund L G. Reliability of routine clearance methods for assessment of glomerular filtration rate in advanced renal insufficiency.  Scand J Clin Lab Invest. 1981;  41 91-97
• 7 Bubeck B. Renal clearance determination with one blood sample: improved accuracy and universal applicability by a new calculation principle.  Semin Nucl Med. 1993;  23 73-86
• 8 Bubeck B, Brandau W, Weber E, Kalble T, Parekh N, Georgi P. Pharmacokinetics of technetium-99m-MAG3 in humans.  J Nucl Med. 1990;  31 1285-1293
• 9 Carlsen J E, Moller M L, Lund J O, Trap-Jensen J. Comparison of four commercial Tc-99m(Sn)DTPA preparations used for the measurement of glomerular filtration rate: concise communication.  J Nucl Med. 1980;  21 126-129
• 10 Chantler C, Barratt T M. Estimation of glomerular filtration rate from plasma clearance of 51-chromium edetic acid.  Arch Dis Child. 1972;  47 613-617
• 11 Chantler C, Garnett E S, Parsons V, Veall N. Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA.  Clin Sci. 1969;  37 169-180
• 12 Christensen A B, Groth S. Determination of 99mTc-DTPA clearance by a single plasma sample method.  Clin Physiol. 1986;  6 579-588
• 13 Cockcroft D W, Gault M H. Prediction of creatinine clearance from serum creatinine.  Nephron. 1976;  16 31-41
• 14 DuBois D, DuBois E. A formula to estimate the approximate surface area if height and weight are known.  Arch Int Med. 1916;  17 863-871
• 15 Durand E, Prigent A. The basics of renal imaging and function studies.  Q J Nucl Med. 2002;  46 249-267
• 16 Durand E, Prigent A, Gaillard J. Comparaison between 9 methods for estimation of glomerular filtration rate (G.F.R.) with simultaneous injections of 51Cr-EDTA and 99mTc-DTPA. In: Taylor A Jr, Nally J, Thomsen H (eds). Radionuclides in nephrology. Society of Nuclear Medicine, Reston 1997; 112-120
• 17 Florijn K W, Barendregt J N, Lentjes E G, van Dam W, Prodjosudjadi W, van Saasa J L. et al . Glomerular filtration rate measurement by “single-shot” injection of inulin.  Kidney Int. 1994;  46 252-259
• 18 Granerus G, Aurell M. Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate.  Scand J Clin Lab Invest. 1981;  41 611-616
• 19 Groth S, Aasted M. 51Cr-EDTA clearance determined by one plasma sample in children.  Clin Physiol. 1984;  4 75-83
• 20 Ham H R, Piepsz A. Estimation of glomerular filtration rate in infants and in children using a single-plasma sample method.  J Nucl Med. 1991;  32 1294-1297
• 21 Kamper A L, Nielsen S L. 51Cr-EDTA plasma clearance in severe renal failure determined by one plasma sample.  Scand J Clin Lab Invest. 1989;  49 555-559
• 22 LaFrance N D, Drew H H, Walser M. Radioisotopic measurement of glomerular filtration rate in severe chronic renal failure.  J Nucl Med. 1988;  29 1927-1930
• 23 Levey A S. Use of glomerular filtration rate measurements to assess the progression of renal disease.  Semin Nephrol. 1989;  9 370-379
• 24 Müller-Suur R. Radiopharmaceuticals: their intrarenal handling and localisation. In: Murray, Ell (eds). Nuclear Medicine in Clinical Diagnosis and Treatment. Churchill-Livingstone, Edinburgh 1998; Kapitel 22
• 25 Müller-Suur R, Magnusson G, Bois-Svensson I, Jansson B. Estimation of technetium 99m mercaptoacetyltriglycine plasma clearance by use of one single plasma sample.  Eur J Nucl Med. 1991;  18 28-31
• 26 Piepsz A, Gordon I, Hahn K, Kolinska J, Kotzerke J, Sixt R. Determination of technetium-99m-mercaptoacetylglycine plasma clearance in children by means of a single blood sample: a multicenter study.  Eur J Nucl Med. 1993;  20 244-248
• 27 Rehling M, Hyldstrup L, Henriksen J H. Arterio-venous concentration difference of [51Cr]EDTA after a single injection in man. Significance of renal function and local blood flow.  Clin Physiol. 1989;  9 279-288
• 28 Rehling M, Moller M L, Thamdrup B, Lund J O, Trap-Jensen J. Simultaneous measurement of renal clearance and plasma clearance of 99mTc-labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man.  Clin Sci. 1984;  66 613-619
• 29 Rehling M, Nielsen S L, Marqversen J. Protein binding of 99mTc-DTPA, 51Cr-EDTA and 125I-iothalamate.  Nucl Med Commun. 1997;  18 324
• 30 Russell C D. Optimum sample times for single-injection, multisample renal clearance methods.  J Nucl Med. 1993;  34 1761-1765
• 31 Russell C D, Bischoff P G, Kontzen F N, Rowell K L, Yester M V, Lloyd L K. et al . Measurement of glomerular filtration rate: single injection plasma clearance method without urine collection.  J Nucl Med. 1985;  26 1243-1247
• 32 Russell C D, Bischoff P G, Rowell K L, Kontzen F, Lloyd L K, Tauxe W N. et al . Quality control of Tc-99m DTPA for measurement of glomerular filtration: concise communication.  J Nucl Med. 1983;  24 722-727
• 33 Russell C D, Taylor A, Eshima D. Estimation of technetium-99m-MAG3 plasma clearance in adults from one or two blood samples.  J Nucl Med. 1989;  30 1955-1959
• 34 Russell C D, Taylor A T, Dubovsky E V. Measurement of renal function with technetium-99m-MAG3 in children and adults.  J Nucl Med. 1996;  37 588-593
• 35 Sapirstein L, Vidt D, Mandel M, Hanusek G. Volumes of distribution and clearances of intravenously injected creatinine in the dog.  Am J Physiol. 1955;  181 330-336
• 36 Stacy B D, Thorburn G D. Chromium-51 ethylenediaminetetraacetate for estimation of globerular filtration rate.  Science. 1966;  152 1076-1077
• 37 Tauxe W, Dubovsky E. Nuclear medicine in clinical urology and nephrology. Appleton-Centring-Crifts, Norwalk 1985
• 38 Tauxe W N, Dubovsky E V, Kidd T, Diaz F, Smith L R. New formulas for the calculation of effective renal plasma flow.  Eur J Nucl Med. 1982;  7 51-54
• 39 Taylor A. Radionuclide renography: a personal approach.  Semin Nucl Med. 1999;  29 102-127
• 40 Taylor A, Hansen L, Eshima D, Malveaux E, Folks R, Shattuck L. et al . Comparison of technetium-99m-ll-EC isomers in rats and humans.  J Nucl Med. 1997;  38 821-826
• 41 Watson W S. A simple method of estimating glomerular filtration rate.  Eur J Nucl Med. 1992;  19 827
• 42 Zimmer A M, Pavel D G. Rapid miniaturized chromatographic quality-control procedures for Tc-99m radiopharmaceuticals.  J Nucl Med. 1977;  18 1230-1233